tykhr
sign in
free sign up
CERo Therapeutics Holdings, Inc. Common Stock
Biotechnology
Healthcare
CERO
1.71 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.49
52 week high
19.83
high
5.60
52 week low
0.00
low
5.35
growth
84.46 %
previous Close
5.49
P/E ratio
-0
market cap
10.00 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
-61.71 %
-3.00 %
eps surprise
-893.72 %
net profit margin
0.00 %
439.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top